Skip to content
Search AI Powered

Latest Stories

Judge Rules That Johnson & Johnson 'Caused the Opioid Epidemic' in Oklahoma, Orders Them to Pay State Damages

Judge Rules That Johnson & Johnson 'Caused the Opioid Epidemic' in Oklahoma, Orders Them to Pay State Damages
Jim Craigmyle/Getty Images; Win McNamee/Getty Images

Finally.

Pharmaceutical manufacturing and sales is a highly profitable business in the United States where drug prices and marketing and sales techniques are not well regulated. While drug manufacturers have to include side effects in TV ads, pharmaceutical companies' marketing to doctors and healthcare facilities remains largely unknown by patients.

Are you getting the best drug for your treatment or the drug that offers your doctor the biggest incentive?


Pharmaceutical companies offer trips, gifts and monetary incentives to doctors and institutions to encourage them to prescribe their products. But now a county district court judge in Oklahoma is holding a pharmaceutical giant accountable for such standard business practices.

Judge Thad Balkman of Cleveland County District Court ruled Monday that Johnson & Johnson pharmaceutical division bears financial liability for the opioid crisis in that state. The judge ordered the company to pay $572 million to Oklahoma to mitigate the costs associated with treatment and detention of people addicted to opiates.

According to Judge Balkman:

"The defendant caused an opioid crisis that is evidenced by increased rates of addiction, overdose deaths and neonatal abstinence syndrome, in Oklahoma."

The case was brought against the company best known for baby shampoo and powder by the state of Oklahoma.

The judge added in his ruling:

"[Johnson & Johnson's] misleading marketing and promotion [of opioids] compromised the health and safety of thousands of Oklahomans."

The drug manufacturer is expected to appeal. Advocates for those affected by the opioid crisis hoped for a larger judgment against the multibillion dollar company.

Judge Balkman explained he was bound by existing law regarding the amount:

"Whether additional programs and funding are needed over an extended period of time, those are determinations to be made by our legislators and policy makers."

The Oklahoma legislature could change the law or impose their own fines.

Johnson & Johnson is not the sole manufacturer of opioids, but 60% of opiates affecting Oklahomans were manufactured at least in part by Johnson & Johnson pharmaceutical.

Oklahoma Attorney General Mike Hunter said:

"Johnson & Johnson, motivated by greed and avarice, is [responsibile] for the opioid epidemic in our state."

AG Hunter added:

"Johnson & Johnson will finally be held accountable for thousands of deaths and addiction caused by their activities."

Hunter's suit against the company asked for $17 billion.

2,000 lawsuits currently face opioid manufacturers. All of the other pending cases were consolidated into one case to be heard in Ohio federal court beginning in October.

Despite the relatively small amount, the judgment is still significant as the first to address the role of pharmaceutical company marketing in substance abuse.

The case is reminiscent of rulings that reshaped alcohol and tobacco advertising and marketing. The potential impact was noted by many.

Johnson & Johnson is expected to appeal the court ruling. Two other pharmaceutical companies previously settled out of court with the state of Oklahoma.

The bestselling book Dopesick: Dealers, Doctors, and the Drug Company that Addicted America is available here.

********

Listen to the first episode of George Takei's podcast, 'Oh Myyy Pod!', where we explore the racially charged videos that have taken the internet by storm.

Be sure to subscribe here and never miss an episode.

More from News

Krypto; Superman
@dcofficial

The New 'Superman' Teaser Just Dropped—And People Are Obsessed With Krypto The Superdog

Comic book movie summer blockbusters: a perennial tradition.

Next summer, a new version of Superman will come to screen, and fans are already excited about the film for many reasons.

Keep ReadingShow less
TikTok screenshots of Mariah Morgenstern
@myahmakesmusic_/TikTok

Non-Famous Woman Who Dated A Celebrity Reveals What It Was Like In Eye-Opening TikTok Series

A woman on TikTok is going viral for revealing what it's like for a non-famous person to date a celebrity.

In a series of videos, TikToker Mariah Morgenstern (@myahmakesmusic_) shared her eye-opening experience being in a relationship with a Hollywood actor.

Keep ReadingShow less
TikTok screenshots of @themundanemum and her toddler
@themundanemum/TikTok

Mom Stunned After Toddler Sees A 'Ghost' As She Hangs Ornament To Honor Late Grandpa In Eerie TikTok

A mom on TikTok left viewers in shock after she shared the moment her toddler saw a "ghost."

The TikToker, Jas (@themundanemum), was left stunned and took to the platform to post the footage.

Keep ReadingShow less
Rihanna; Mariah Carey
Cindy Ord/WireImage/GettyImages, Kevin Mazur/Getty Images for Mariah Carey

Mariah Carey Just Signed Rihanna's Boob—And Rihanna's Reaction Is Everything

Mariah Carey made quite an impression on pop sensation Rihanna—right on her left boob.

Carey embarked on her Christmas Time tour on November 6 to celebrate the 30th anniversary of her iconic Merry Christmas album.

Keep ReadingShow less
Donald Trump; Elon Musk
Josh Edelson/AFP via Getty Images; Samuel Corum/Getty Images

Trump Explains Why He's 'Safe' From Musk Becoming President In Bonkers Speech

During a speech at Turning Point USA's AmericaFest conference, President-elect Donald Trump rejected claims that his billionaire ally Elon Musk is overshadowing him following backlash over Musk's role in blocking the emergency spending measure to prevent a government shutdown.

Trump dismissed the idea that he had “ceded the presidency” to Musk. He added that even if Musk aspired to the role, he wouldn’t qualify due to the Constitution’s stipulation that the U.S. president must be a natural-born citizen—a requirement Musk, born in South Africa, does not meet.

Keep ReadingShow less